Published 2011 | Version v1
Publication

Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia.

Additional details

Identifiers

URL
http://hdl.handle.net/11567/390433
URN
urn:oai:iris.unige.it:11567/390433

Origin repository

Origin repository
UNIGE